Sean Parker’s I/O group teams up with CRI for cancer neoantigens R&D deal

Facebook and Napster billionaire Sean Parker has seen his Institute for Cancer Immunotherapy join forces with the Cancer Research Institute (CRI) to work on boosting personalized medicine.

Visit FIERCEBIOTECH.COM to view the full article.